Home
About
Overview
Sharing Data
ORCID
Help
History (48)
An architectural genetic and epigenetic perspective.
Recent developments in recombinant AAV-mediated gene therapy for lung diseases.
Chernosky, Patricia
Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population.
Formulary conversion programs: the need for patient-specific risk assessment.
See All 48 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Formulary conversion programs: the need for patient-specific risk assessment.
Singh S, Shrivastava R, Das V. Formulary conversion programs: the need for patient-specific risk assessment. MedGenMed. 2004 Sep 14; 6(3):28.
View in:
PubMed
subject areas
Aged
Cyclosporine
Drug Interactions
Female
Formularies as Topic
Heart Transplantation
Heptanoic Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
Postoperative Care
Pyrroles
Rhabdomyolysis
Risk Assessment
Simvastatin
authors with profiles
Sonal Singh MD, MPH